Klox Technologies (KLOX) Files for $75M IPO

Klox Technologies, Inc. (Nasdaq: KLOX) filed a registration with the U.S. SEC for an IPO of its Common Stock. The proposed maximum offering price is $75 million. The company plans to list on the Nasdaq Global Market under the symbol, KLOX.

The offering is being made via UBS Investment Bank, Canaccord Genuity, Needham & Company, and National Bank of Canada Financial Inc.

Klox Tech is a specialty pharmaceutical company focused on developing and commercializing products based on our proprietary BioPhotonic technology platform to address skin and soft tissue disorders.

Klox also said, Initially, we intend to focus on indications in the areas of dermatology, wound care and oral health. LumiCleanse and LumiBel, our dermatology treatment systems for acne vulgaris and cosmetic skin care, respectively, are being commercialized with leading global collaborators in Canada and Europe. The gel component of LumiHeal, our wound healing treatment system, has received European marketing authorization, and we intend to commercialize this product on our own. We anticipate commercial launch of LumiCleanse, LumiBel and LumiHeal in Europe in 2015. We are also developing our oral health franchise, including PERIO-1 for the treatment of periodontitis, and we intend to file for Conformité Européenne, or CE, mark approval for PERIO-1 in 2015. The CE mark is an international symbol that represents adherence to certain essential principles of safety and effectiveness mandated in the European Medical Device Directive and, once affixed, enables a product to be sold within the European Union and other countries that recognize the CE mark, subject to compliance with applicable submission and approval requirements in such other countries. Through our collaborators’ efforts and our own, we plan to commercialize these and future treatment systems worldwide.

You May Also Be Interested In

• Jersey Mike's closes IPO at $23 per share on NYSE
• Churchill Capital Corp XIII prices $360 million IPO on Nasdaq
• Recon Technology launches $100M at-the-market equity offering